Scientific Publications

Comprehensive functional annotation of 77 prostate cancer risk Loci.

Publication TypeJournal Article
AuthorsHazelett, DJ, Rhie SK, Gaddis M., Yan C., Lakeland DL, Coetzee SG, consortium Ellipse/GAME-ON, consortium Practical, Henderson BE, Noushmehr H., Cozen W., Kote-Jarai Z., Eeles RA, Easton DF, Haiman CA, Lu W., Farnham PJ, and Coetzee GA
AbstractGenome-wide association studies (GWAS) have revolutionized the field of cancer genetics, but the causal links between increased genetic risk and onset/progression of disease processes remain to be identified. Here we report the first step in such an endeavor for prostate cancer. We provide a comprehensive annotation of the 77 known risk loci, based upon highly correlated variants in biologically relevant chromatin annotations- we identified 727 such potentially functional SNPs. We also provide a detailed account of possible protein disruption, microRNA target sequence disruption and regulatory response element disruption of all correlated SNPs at [Formula: see text]. 88% of the 727 SNPs fall within putative enhancers, and many alter critical residues in the response elements of transcription factors known to be involved in prostate biology. We define as risk enhancers those regions with enhancer chromatin biofeatures in prostate-derived cell lines with prostate-cancer correlated SNPs. To aid the identification of these enhancers, we performed genomewide ChIP-seq for H3K27-acetylation, a mark of actively engaged enhancers, as well as the transcription factor TCF7L2. We analyzed in depth three variants in risk enhancers, two of which show significantly altered androgen sensitivity in LNCaP cells. This includes rs4907792, that is in linkage disequilibrium ([Formula: see text]) with an eQTL for NUDT11 (on the X chromosome) in prostate tissue, and rs10486567, the index SNP in intron 3 of the JAZF1 gene on chromosome 7. Rs4907792 is within a critical residue of a strong consensus androgen response element that is interrupted in the protective allele, resulting in a 56% decrease in its androgen sensitivity, whereas rs10486567 affects both NKX3-1 and FOXA-AR motifs where the risk allele results in a 39% increase in basal activity and a 28% fold-increase in androgen stimulated enhancer activity. Identification of such enhancer variants and their potential target genes represents a preliminary step in connecting risk to disease process.
Year of Publication2014
JournalPLoS genetics
Volume10
Issue1
Pagese1004102
Date Published (YYYY/MM/DD)2014/01/01
ISSN Number1553-7390
DOI10.1371/journal.pgen.1004102
PubMedhttp://www.ncbi.nlm.nih.gov/pubmed/24497837?dopt=Abstract